Pura Vida Investments, LLC Natera, Inc. Call Options Transaction History

Pura Vida Investments, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 13, 2024	BUY	$37.55 - $62.64 $1.81 Million - $3.02 Million	48,200 New	48,200 $3.02 Million
Q1 2020 May 15, 2020	SELL	$17.27 - $40.17 $932,580 - $2.17 Million	-54,000 Closed	0 $0
Q4 2019 Feb 12, 2021	BUY	$32.1 - $40.4 $1.72 Million - $2.16 Million	53,460 Added 9900.0%	54,000 $1.82 Million
Q4 2019 Feb 14, 2020	BUY	$32.1 - $40.4 $17,334 - $21,816	540 New	540 $10,000

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.